Breaking News

ACM Global Appoints Clinical Ops VP

April 9, 2013

Jackle to oversee U.S.-based clinical trials

Timo Jackle has been appointed to the executive management team as vice president of clinical trials operations at ACM Global Central Lab. Mr. Jackle will be responsible for overseeing project management, data management, study support, specimen management, and logistics activities for all of ACM’s U.S.-based clinical trials, as well as developing and implementing its strategy for operations globally.
 
Mr. Jackle joins the company from Bausch & Lomb (B&L), where he most recently served as executive director of global clinical trials operations, responsible for overseeing multi-national pharmaceutical and medical device clinical trials. Prior to that, he was based in Germany, where he served as director of global refractive R&D and R&D site leader for B&L’s refractive surgery subsidiary. 
 
“Timo is a highly collaborative leader with extensive experience in clinical trials research, quality assurance, global operations, and business process improvement,” said Angela J. Panzarella, president of ACM Global Central Lab. “His strong focus on customer service and lengthy track record in improving business processes will no doubt be an asset to our clients.”

Related Packaging:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research